BVT Aktienanleihe AMD 31.12.2024/ DE000VM6K6F3 /
2024-10-11 5:04:12 PM | Chg.+0.090 | Bid7:08:18 PM | Ask7:08:18 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
100.890EUR | +0.09% | 100.910 Bid Size: 500,000 |
101.010 Ask Size: 500,000 |
Advanced Micro Devic... | 95.00 USD | 2024-12-31 | Call |
GlobeNewswire
09-01
Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer
GlobeNewswire
08-27
Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CL...
GlobeNewswire
08-27
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
GlobeNewswire
08-26
Aura Biosciences Announces the Presentation of Phase 2 End of Study Data Evaluating Suprachoroidal A...
GlobeNewswire
08-23
AiViva Biopharma Completes Enrollment in a Phase 1 Clinical Trial of AIV007 for Age-Related Macular ...
GlobeNewswire
08-21
AMD 2023-24 Corporate Responsibility Report: Advancing Sustainability, Collaboration and Inclusion
GlobeNewswire
08-20
FUJIFILM Diosynth Biotechnologies Celebrates Opening of Billingham, UK Microbial Manufacturing Facil...
GlobeNewswire
08-20
Gamescom 2024 - HP Elevates the Gaming World through Customizable Solutions for a Personalized Playe...
GlobeNewswire
08-19
AMD to Significantly Expand Data Center AI Systems Capabilities with Acquisition of Hyperscale Solut...